What does Theraclion S.A. do?

Theraclion S.A. (TCLIF) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is TCLIF's market cap?

Theraclion S.A. (TCLIF) has a market capitalization of approximately $38.9 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does TCLIF pay a dividend?

No — Theraclion S.A. (TCLIF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Theraclion S.A. (TCLIF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

TCLIF

Theraclion S.A.

OTC·Medical, Devices · Healthcare

$0.53$0.00+0.00%

Market cap$38.89M·Market closed·Aug 26 8:00 PM UTC

Price Chart

$0.53+$0.00 (+0.00%)today

−74.42%CAGR −23.89%

Select date range

FromTo

Apr 22, 2019Aug 28, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

TCLIF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateOct 26

Last Report DateApr 27

Reported vs Estimate−$0.06

Earnings Surprise—

FinancialsFinancials Tab

Revenue€1.30M

Net Income−€5.70M

Net Margin−440.1%

Operating Cash Flow−€3.58M

Capital Expenditures€212.17K

Free Cash Flow−€3.79M

Return on Equity—

Return on Invested Capital−22.5%

Net Debt€1.71M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for TCLIF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how TCLIF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TCLIF and 80,000+ other tickers.

About Theraclion S.A.

Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solution, utilized for addressing thyroid nodules and breast fibroadenomas. The company further provides EPack, a disposable accessory that attaches to the treatment device to ensure patient skin protection and improve imaging precision. Founded in 2004, Theraclion SA is headquartered in Malakoff, France.

CEO: Martin Deterre
Sector: Healthcare
Industry: Medical - Devices
Exchange: OTC
Employees: 36
Website: www.theraclion.com

Peers

Southwestern Medical Solutions, Inc.

Cap

$2.5K

WPHM

Winston Pharmaceuticals, Inc.

Cap

$7.7K

Latest News

News Tab

No recent news available.

Frequently Asked Questions About TCLIF

What does Theraclion S.A. do?: Theraclion S.A. (TCLIF) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is TCLIF's market cap?: Theraclion S.A. (TCLIF) has a market capitalization of approximately $38.9 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does TCLIF pay a dividend?: No — Theraclion S.A. (TCLIF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is TCLIF profitable?: Theraclion S.A. (TCLIF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.